Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Duster340 on Feb 24, 2023 3:02pm

Back to 60 cents

Looks like the troll missed out


ATE - Next Entry Point C$ 0.45 or Lower
I have been on the sidelines since mid January watching for the next ATE entry point. I now see a slow decline in the stock share price into the low to mid C$ 0.40s.  That could be my entry point.

Now that the 2023 Q3 financials have been released along with corporate updates from management, there is nothing ATE investors can do but wait for hopefully postive news. With the general negative sentiment in the markets, it is inevitable that there will be more selling of ATE stock due to investor fatigue.
ATE - Next Entry Point C$ 0.45 or Lower
I have been on the sidelines since mid January watching for the next ATE entry point. I now see a slow decline in the stock share price into the low to mid C$ 0.40s.  That could be my entry point.

Now that the 2023 Q3 financials have been released along with corporate updates from management, there is nothing ATE investors can do but wait for hopefully postive news. With the general negative sentiment in the markets, it is inevitable that there will be more selling of ATE stock due to investor fatigue.
Comment by davgro on Feb 24, 2023 3:20pm
It was one buyer at TD who placed a large order at the bid.  Price will not be maintained and will drop back to mid C$0.50s very quickly. You understand nothing about trading.  While you try to flip pennies with low volume stocks like ATE I made a killing today on HEXO swing trades.  Add to the fact that last week I made $13K profit in HEXO in 4 days swing trading.  You ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities